Aldeyra Therapeutics (ALDX) Stock Price, Quote, News & History | Benzinga

Aldeyra Therapeutics Inc (ALDX) Stock Price, Quote, News & History

ALDXNASDAQ

Trade with Public

Trade with Public

$1.48

-0.005-0.34%

At close: Aug 31, 5:00 PM EST

$1.56

0.085.41%

After Hours: 5:48 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$1.51

Close

$1.48

Volume / Avg.

495.39K / 1.30M

Day Range

$1.47 - $1.51

52 Wk Range

1.07 - 6.18

Market Cap

$94.11M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

5.69%

Days to Cover

3.81

Recent Aldeyra Therapeutics Inc News

What's Going On With Aldeyra Therapeutics Stock On Thursday?

Aldeyra stock plunges after FDA rejects its dry eye drug reproxalap, raising concerns over efficacy and future growth prospects.

Vandana Singh

Oil Prices Spike To $98, Stocks Dip After Israeli Attack On Iran's Gas Facilities

U.S. stocks fell ahead of the Fed decision after February PPI topped forecasts, while Brent crude surged above $108.

Piero Cingari

This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Analysts downgraded CF, ALDX, TTD, TME and DUOL. Check their ratings and price targets. Interested in TTD? See what analysts say.

Avi Kapoor

FDA Rejects Aldeyra's Dry Eye Drug For Third Time, Stock Crashes 68%

Aldeyra stock crashes 68% after the FDA rejects its dry eye drug, reproxalap, for the third time. Get the full regulatory update here.

Vandana Singh

Crude Oil Gains Around 2%; Elbit Systems Shares Jump On Upbeat Earnings

US stocks rose, with Dow Jones up 0.39% & NASDAQ up 0.59%. Energy shares jumped 1.7%, while industrials fell 0.1%. Elbit Systems shares up 10%.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-22.02M

Investing Cash Flow (TTM)

40.98M

Financing Cash Flow (TTM)

-15.11M

Free Cash Flow (TTM)

-22.04M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

3.85M

Analyst Trends and Forecast

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$44.64M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

2.36

Earnings Yield % (TTM)

-25.59%

Earnings Yield % (FWD)

-26.26%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.63

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$15.30M

Total Cash

$45.09M

Debt to Equity

0.00

Issuance of Debt (TTM)

-$15.30M

Repayment of Debt (TTM)

-$15.30M

Key Statistics

Open

$1.51

Close

$1.48

Volume / Avg.

495.39K / 1.30M

Day Range

$1.47 - $1.51

52 Wk Range

1.07 - 6.18

Market Cap

$94.11M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

5.69%

Days to Cover

3.81

About

Sector

Health Care

Industry

Biotechnology

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a tr...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Aldeyra Therapeutics (ALDX) stock?

A

You can purchase shares of Aldeyra Therapeutics (NASDAQ:ALDX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Aldeyra Therapeutics (ALDX) competitors?

A

Other companies in Aldeyra Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Aldeyra Therapeutics (ALDX) stock?

A

Aldeyra Therapeutics has a consensus price target of $7.25.

Q

What is the current price for Aldeyra Therapeutics (ALDX)?

A

The stock price for Aldeyra Therapeutics (NASDAQ: ALDX) is $1.56 last updated August 31, 2026 at 5:48 PM EDT.

Q

Does Aldeyra Therapeutics (ALDX) pay a dividend?

A

There are no upcoming dividends for Aldeyra Therapeutics.

Q

When is Aldeyra Therapeutics (NASDAQ:ALDX) reporting earnings?

A

Aldeyra Therapeutics does not have any upcoming earnings scheduled.

Q

Is Aldeyra Therapeutics (ALDX) going to split?

A

There is no upcoming split for Aldeyra Therapeutics.

Q

What sector and industry does Aldeyra Therapeutics (ALDX) operate in?

A

Aldeyra Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.